X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dishman Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dishman Pharma Quarterly Results   (DHPH)

Here are the latest quarterly results of Dishman Pharma. For more details, see the Dishman Pharma financial fact sheet and Dishman Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dishman Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m4,0053,8123,8874,2213,7544,3663,6215,342 
Other income Rs m417617130707715538 
Turnover Rs m4,0473,8883,9044,3513,8244,4423,7765,380 
Expenses Rs m2,9612,8972,7873,1752,7323,2082,6643,875 
Gross profit Rs m1,0449151,1001,0461,0221,1589531,462 
Depreciation Rs m259261271299285309293570 
Interest Rs m319236185205225189134101 
Profit before tax Rs m507494661672583736682829 
Tax Rs m130129191174127190175401 
Profit after tax Rs m378365469498455547507428 
Gross profit margin %26.124.028.324.827.226.526.327.4 
Effective tax rate %25.626.129.025.821.925.825.748.4 
Net profit margin %9.49.612.111.812.112.514.08.0 
Diluted EPS Rs 2.3 2.3 2.9 3.1 2.8 3.4 3.1 2.7  
Diluted EPS (TTM) Rs 8.3 8.5 9.9 10.6 11.1 12.2 12.4 12.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   FULFORD INDIA  DR. REDDYS LAB  ALEMBIC PHARMA  J.B.CHEMICALS  ELDER PHARMA  

Compare DISHMAN PHARMA With:   FULFORD INDIA  DR. REDDYS LAB  ALEMBIC PHARMA  J.B.CHEMICALS  ELDER PHARMA  

Compare DISHMAN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Will Low Inflation Encourage RBI to Cut Rates?(Podcast)

In a week full of macroeconomic developments, anxiety over third quarter results and trade war concerns, we take a look at the key topics that swayed the markets this week.

Views on news

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

The Biggest Trend That I'm Seeing in the Market Today(The 5 Minute Wrapup)

Jan 10, 2019

For the first time ever, a majority of Indian households, will start to benefit from stock market wealth.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

A Proven Super Investor Can Lead to Great Wealth(Profit Hunter)

Jan 7, 2019

Following a super investor can certainly help build a portfolio that can create significant wealth in the long term.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA - TEVA PHARMA COMPARISON

COMPARE DISHMAN PHARMA WITH

MARKET STATS